Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) — Financial Flexibility Index
Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) has a Financial Flexibility Index of 0.10x as of December 2025. Free cash flow of CN¥18.27 Million (operating CF CN¥-26.19 Million minus capex CN¥44.45 Million) represents 0% of total liabilities (CN¥181.12 Million). Check total reinvestment intensity of Xinxiang Tuoxin Pharmaceutical Co.Ltd. to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Xinxiang Tuoxin Pharmaceutical Co.Ltd. Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Xinxiang Tuoxin Pharmaceutical Co.Ltd. across 7 annual periods. For the full cash flow conversion analysis, see Xinxiang Tuoxin Pharmaceutical Co.Ltd. cash flow conversion.
Annual Financial Flexibility Index for Xinxiang Tuoxin Pharmaceutical Co.Ltd. (2019–2025)
Year-by-year free cash flow to debt coverage for Xinxiang Tuoxin Pharmaceutical Co.Ltd.. Explore 301089 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.10x | CN¥18.27 Million | CN¥-26.19 Million | CN¥181.12 Million | ▼ -88.9% |
| 2024 | 0.91x | CN¥186.58 Million | CN¥102.67 Million | CN¥205.72 Million | ▲ +0.8% |
| 2023 | 0.90x | CN¥212.17 Million | CN¥26.95 Million | CN¥235.72 Million | ▲ +0.7% |
| 2022 | 0.89x | CN¥417.18 Million | CN¥268.85 Million | CN¥466.89 Million | ▲ +54.9% |
| 2021 | 0.58x | CN¥170.92 Million | CN¥58.19 Million | CN¥296.35 Million | ▲ +35.4% |
| 2020 | 0.43x | CN¥194.12 Million | CN¥120.00 Million | CN¥455.61 Million | ▼ -6.5% |
| 2019 | 0.46x | CN¥162.58 Million | CN¥86.38 Million | CN¥356.74 Million | — |